Zev A. Wainberg

Jan 25, 2025 | onclive.com | Zev A. Wainberg

CommentaryVideoJanuary 25, 2025Author(s):Fact checked by:Zev A. Wainberg, MD, discusses findings from the phase 2/3 ASPEN-06 trial (NCT05002127) of evorpacept plus trastuzumab, ramucirumab, and paclitaxel in HER2-overexpressing gastric/GEJ cancer. Zev A.

Oct 1, 2024 | cancernetwork.com | Zev A. Wainberg |Eileen M. O'Reilly

Pancreatic cancers have the dubious distinction of having the lowest survival rates of any major cancer, with an overall 5-year relative survival of only 13%.1 The majority of pancreatic cancers are detected after they have already spread, with 29% of cases involving regional lymph nodes and 51% of patients receiving a diagnosis of metastatic cancer.

Jun 26, 2024 | medscape.com | Samuel J. Klempner |Zev A. Wainberg

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Samuel J. Klempner, MD: Hello. My name is Dr Sam Klempner. I'm a gastrointestinal (GI) medical oncologist at Mass General in Boston. Welcome to the Medscape InDiscussion: Esophageal Cancer podcast series.

Mar 28, 2024 | mdpi.com | Faithlore Gardner |Zev A. Wainberg |Christos Fountzilas |Nathan Bahary

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Mar 11, 2024 | onclive.com | Zev A. Wainberg

Welcome to OncLive On Air®! I’m your host today, Ashling Wahner. OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions. In today’s episode, sponsored by Ipsen, we had the pleasure of speaking with Zev A.